Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Insulin isophane biphasic human 50/50 100u/ml inj 3ml cart
0601012D0AABUBU
|
Biphasic isophane insulin | Biphasic isophane insulin | Endocrine System | 1 |
|
Insulin lispro biphasic 50/50 100units/ml inj 3ml cartridges
0601012F0AAADAD
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | 1 |
|
Insulin soluble human 100units/ml inj 3ml cartridges
0601011N0AAAPAP
|
Insulin soluble | Soluble insulin (Neutral insulin) | Endocrine System | 1 |
|
Iodine aqueous oral solution
0602020G0AAABAB
|
Iodine (Systemic) | Iodine | Endocrine System | 1 |
|
Jesacrin 750mg modified-release tablets
0601022B0BTAAAT
|
Jesacrin | Metformin hydrochloride | Endocrine System | 1 |
|
Lamzarin 60mg modified-release tablets
0601021M0BQABAT
|
Lamzarin | Gliclazide | Endocrine System | 1 |
|
Levothyroxine 35microgram / Liothyronine 8microgram tablets
0602010Z0AAAJAJ
|
Levothyroxine sodium/liothyronine | Levothyroxine sodium and liothyronine | Endocrine System | 1 |
|
Levothyroxine sodium 10microgram capsules
0602010V0AACICI
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 12.5microgram capsules
0602010V0AABMBM
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 19microg / Liothyronine 4.5microg tab
0602010Z0AAAAAA
|
Levothyroxine sodium/liothyronine | Levothyroxine sodium and liothyronine | Endocrine System | 1 |
|
Levothyroxine sodium 2.5mg/5ml oral liquid
0602010V0AAFBFB
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 200micrograms inj vials
0602010V0AAFWFW
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1 |
|
Levothyroxine sodium 76microg / Liothyronine 18microg tab
0602010Z0AAADAD
|
Levothyroxine sodium/liothyronine | Levothyroxine sodium and liothyronine | Endocrine System | 1 |
|
Lyxumia 10micrograms/20micrograms treatment initiation pack
0601023AIBBACAC
|
Lyxumia | Lixisenatide | Endocrine System | 1 |
|
MediTouch 2 testing strips
0601060D0DIABA0
|
MediTouch (Reagent) | Glucose blood testing reagents | Endocrine System | 1 |
|
Mendor Discreet testing strips
0601060D0DFAAA0
|
Mendor Discreet (Reagent) | Glucose blood testing reagents | Endocrine System | 1 |
|
Menopur 1,200unit inj vials
0605010N0BFACAH
|
Menopur | Menotrophin | Endocrine System | 1 |
|
Menorest 75 patches
0604011G0BJACBR
|
Menorest | Estradiol | Endocrine System | 1 |
|
Meriofert 150unit inj vials
0605010N0BHABAF
|
Meriofert | Menotrophin | Endocrine System | 1 |
|
Methylprednisolone aceponate 0.1% ointment
0603020ACAAAAAA
|
Methylprednisolone aceponate | Methylprednisolone aceponate | Endocrine System | 1 |
|
Methylprednisolone sodium succinate 125mg inj vials
0603020K0AAABAB
|
Methylprednisolone sodium succinate | Methylprednisolone sodium succinate | Endocrine System | 1 |
|
Mixtard 30 Penfill 100units/ml inj 3ml cartridges
0601012D0BCBABA
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | 1 |
|
Movymia 20micrograms/80microlitres dose inj 2.4ml cartridge
0606010U0BDABAE
|
Movymia | Teriparatide | Endocrine System | 1 |
|
Nature-Throid 32.5mg (half grain) tablets
0602010Z0BDABAA
|
Nature-Throid | Levothyroxine sodium and liothyronine | Endocrine System | 1 |
|
NP Thyroid 30mg (half grain) tablets
0602010Z0BFAAAA
|
NP Thyroid | Levothyroxine sodium and liothyronine | Endocrine System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.